Karuna Therapeutics, Inc. logo

Karuna Therapeutics, Inc.

NASDAQ:KRTX

Overview | Financials
Company Name Karuna Therapeutics, Inc.
Symbol KRTX
Currency USD
Price 329.83
Market Cap 12,599,275,119
Dividend Yield 0%
52-week-range 158.375 - 329.99
Industry Biotechnology
Sector Healthcare
CEO Mr. William Meury
Website https://www.karunatx.com

An error occurred while fetching data.

About Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and

Related Stocks

Patterson Companies, Inc. logo

Patterson Companies, Inc.

PDCO

20.7 USD

Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc.

VIR

7.76 USD

Mirati Therapeutics, Inc. logo

Mirati Therapeutics, Inc.

MRTX

58.7 USD

Intellia Therapeutics, Inc. logo

Intellia Therapeutics, Inc.

NTLA

19.72 USD

Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc.

RARE

55.24 USD

GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc.

GDRX

7.71 USD

Inari Medical, Inc. logo

Inari Medical, Inc.

NARI

45.52 USD

Certara, Inc. logo

Certara, Inc.

CERT

11.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD